ErVimmune
PrivateLast Round
Series A
Jan 21, 2026
Total Funding Raised
$7.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ErVimmune is a biotechnology company developing therapeutic vaccines and cell therapies to treat cancers that do not respond to current immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ErVimmune Comparables
Compare ErVimmune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hervolution Therapeutics | 88% | |
| Brenus Pharma | 82% | |
| Infinitopes Precision Immunomics | 73% | |
ErVimmune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 21, 2026 | ||||
| Grant | Nov 1, 2023 | ||||
| Seed | Jan 9, 2023 |
ErVimmune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIM Global Investments | Series A |
| EIC Accelerator | Grant |
| SPRIM Global Investments | Series A |
| Bpifrance | Seed |
| Seventure Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 271% MoM, reaching 899.
- Jan 21, 2026
$20M raised in Series A financing.
ErVimmune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ErVimmune's valuation, stock price, and market status.